Shiloh
Editor, Senior Moderator
Source: https://www.news-medical.net/news/2...fizer-vaccination-4025-immunocompromised.aspx
Israeli study of breakthrough infections following full BNT-Pfizer vaccination, 40% immunocompromised
Dr. Tomislav Meštrović, MD, Ph.D.By Dr. Tomislav Meštrović, MD, Ph.D.Jul 13 2021
Severe forms of coronavirus disease (COVID-19) linked to high mortality rates might arise in a minority of fully-vaccinated individuals with many co-occurring medical conditions, finds a recent study by Israeli researchers published in the journal Clinical Microbiology and Infection.
In Phase III clinical trials, two mRNA COVID-19 vaccines (Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273) were shown to be 94-95% effective in preventing symptomatic forms of the disease. Moreover, similar efficacy was observed in different age groups, as well as in those older than 75 and those with comorbidities...
Israeli study of breakthrough infections following full BNT-Pfizer vaccination, 40% immunocompromised
Dr. Tomislav Meštrović, MD, Ph.D.By Dr. Tomislav Meštrović, MD, Ph.D.Jul 13 2021
Severe forms of coronavirus disease (COVID-19) linked to high mortality rates might arise in a minority of fully-vaccinated individuals with many co-occurring medical conditions, finds a recent study by Israeli researchers published in the journal Clinical Microbiology and Infection.
In Phase III clinical trials, two mRNA COVID-19 vaccines (Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273) were shown to be 94-95% effective in preventing symptomatic forms of the disease. Moreover, similar efficacy was observed in different age groups, as well as in those older than 75 and those with comorbidities...